Nu-Med Plus, Inc. filed a Current Report on Form 8-K on November 2, 2026, announcing amendments to its corporate bylaws. The Board of Directors adopted an amendment to the Bylaws effective immediately on that date. The change adds a new section confirming that any transfer of the company’s domicile to a jurisdiction other than Utah, or the domestication of the company in a different jurisdiction, requires the affirmative vote of a majority of the votes cast by the shares entitled to vote. This requirement applies to votes cast in person or by proxy at a meeting where a quorum is present.
The filing also details the schedule for the Company’s 2026 Annual Meeting of Shareholders. The Board has determined that the meeting will be held virtually on December 14, 2026, though the date is subject to change. Shareholders of record as of the close of business on November 6, 2026, are entitled to notice and voting rights, provided the record date remains unchanged.
The Company has established a deadline for shareholder proposals and director nominations to be included in the proxy materials. Any proposal intended for inclusion in the proxy statement for the 2026 Annual Meeting must be delivered to the principal executive offices at 640 Belle Terre Rd., Building 2 E, Port Jefferson, NY 11777, or mailed to arrive by the close of business on November 13, 2026. Proposals submitted after this deadline will be considered untimely and will not be brought before the meeting.
